

/39/
As Israeli companies continue to be attracted to the American market—and as U.S. investors, in turn, covet cutting-
edge Israeli technologies—our Israel practice group continues to assist parties from both countries. We have over
two decades’ experience helping Israeli companies enter U.S. markets and engage in deals with U.S. investors and
partners. We regularly handle strategic transactions on behalf of both public and private Israeli entities, and we have
been instrumental in a large number of public equity financings of U.S.-listed Israeli companies.
Wehave longenjoyeddeep ties to the Israeli business community,andour strong relationshipswith Israeli legal andaccounting
firms make us ideal partners in the structuring of a variety of M&A and capital markets transactions for the American market.
We are sensitive to the differences in the two business cultures, and have grown adept at translating between them.
What needs no translation is the pragmatic, “get-it-done” approach we bring to all our transactions firm-wide—an
approach very much attuned to the results-oriented predispositions of our Israeli clients.
Chambers Global (2015) selected Kramer Levin’s Israel practice as one of the best in the legal field in the area of
Corporate/M&A: Foreign Experts (Based Abroad). Clients remarked that “[Kramer Levin] has a very long pedigree of
working with Israeli companies.”
Drawing from the various disciplines within the firm, our services include:
Capital markets transactions; Early stage representation; Fund formation; Intellectual property and technology law;
Labor and executive compensation law; Litigation; Mergers and acquisitions; Securities law compliance; Taxation.
Kevin P. Scanlan is the chair of Kramer Levin’s Private Funds practice. He advises clients on structuring, forming and
investing in international and domestic private investment funds, including hedge funds, private equity funds, real
estate funds, venture capital funds and fund-of-funds. In addition, Mr. Scanlan advises funds in connection with their
subsequent investment activities. He represents large, well-established funds and managers as well as first-time funds
of high-quality emerging managers.
Mr. Scanlan is a member of the Managed Funds Association Outside Counsel Forum and the New York State Bar
Association Private Investment Funds Subcommittee, as well as a Faculty Professor of the Regulatory Compliance
Association’s CCO University. In 2014, Mr. Scanlan received The American Lawyer’s “Global Pro Bono Deal of the
Year, Social Enterprise.” The award recognized his work as lead partner on a transaction involving the establishment
of an investment fund and the structuring of an innovative loan made by the fund to smallholder farmers in the cacao
industry in Belize. Mr. Scanlan was named one of Institutional Investor News’ “Rising Stars of Hedge Funds” in 2009
and is recommended by The Legal 500 (US) in the area of alternative/hedge funds.
Darina F. Delappe contributed to this article. Ms. Delappe is a special counsel in Kramer Levin’s Private Funds practice.
She advises both sponsors and investors on the formation, management and restructuring of international and
domestic private investment funds. Ms. Delappe also advises clients on seed investments, the organization of joint
ventures and various compliance matters.
Kramer Levin Naftalis
& Frankel LLP
Kevin P. Scanlan, Partner and Chair, Darina F. Delappe, Special CounselCONTACT
INFORMATION:
www.kramerlevin.comoffice: +1 212.715.9400
kscanlan@kramerlevin.com/
ddelappe@kramerlevin.com